SAGE - Sage granted FDA orphan tag for Huntington's disease therapy
2023-10-18 11:28:36 ET
More on Sage
- Sage Therapeutics: Undeserving Selloff Presents A Buying Opportunity
- Sage Therapeutics, Inc. (SAGE) Business Update Call (Transcript)
- Sage Therapeutics' Zuranolone Is A Lost Cause In Depression Market
- Sage cuts 40% of staff in portfolio shake-up ahead of Zurzuvae launch
- Biogen/ Sage expected to hike price for new depression drug after narrow label
For further details see:
Sage granted FDA orphan tag for Huntington’s disease therapy